Department of Cardiology, Yeditepe University Hospital, Hastahane Sok. No: 4, 34752, Istanbul, Turkey.
Department of Cardiology, Erasmus University Medical Center, Rotterdam, the Netherlands.
J Interv Card Electrophysiol. 2023 Mar;66(2):363-372. doi: 10.1007/s10840-022-01264-3. Epub 2022 Jun 22.
To investigate the effect of successful RFCA in patients with idiopathic outflow tract PVCs (OT-PVC) on left heart functions, neurohormonal activation, functional status, and heart failure-related quality of life (HFQoL), with an integrated approach.
Patients with frequent OT-PVCs, determined by 12-lead surface ECG who underwent radiofrequency catheter ablation (RFCA) with an acute success, were prospectivelly enrolled. Left heart functions were evaluated with the use of transthoracic echocardiography, neurohormonal activation with N-terminal Pro-brain natriuretic peptide (BNP), functional class with New York Heart Association (NYHA) and 6-min walking distance (6MWD), and HFQoL with Minnesota Living with Heart Failure Questionnaire (MLHFQ), at baseline and at 6 months.
A total of 108 patients were included in this study (43 ± 12 years old, 56% male). Majority of the OT-PVCs originated from aortic valve and right ventricle outflow tract (44% and 37%, respectively). Total RF time was 216 ± 87 s. Major complication rate was 0.9%. Left ventricle (LV) ejection fraction increased from 47 ± 8 to 53 ± 6% at 6 months (p < 0.001). Neurohormonal activation was suppressed significantly (104 ± 69 to 83 ± 42, p < 0.001). Functional class improved with %NYHA-I patients increasing from 54 to 89% (p < 0.001) and 6MWD from 293 ± 73 to 335 ± 59 m (p < 0.001). MLHFQ score improved from 32 ± 9 to 23 ± 5 p < 0.001. In multivariable analysis, LV end-systolic diameter (LVESD) and 6MWD were independent predictors of improvement in MLHFQ (for LVESD Uβ: - 0.26, 95%CI [0.44-0.09], p < 0.004 and for 6MWD: 0.04, 95%CI [0.03-0.06], p < 0.001).
RFCA of OT-PVCs is associated with improved well-being of patients, determined by left heart functions, neurohormonal activation, functional class, and HFQoL.
本研究旨在采用综合方法探讨特发性流出道 PVC(OT-PVC)射频消融(RFCA)成功对左心功能、神经激素激活、功能状态和心衰相关生活质量(HFQoL)的影响。
本前瞻性研究纳入了通过 12 导联体表心电图确定频发 OT-PVC 并接受 RFCA 治疗的患者。使用经胸超声心动图评估左心功能,用 N 端脑利钠肽前体(BNP)评估神经激素激活,用纽约心脏协会(NYHA)心功能分级和 6 分钟步行距离(6MWD)评估功能状态,用明尼苏达州心衰生活质量问卷(MLHFQ)评估心衰相关生活质量。所有患者在基线和 6 个月时进行上述评估。
本研究共纳入 108 例患者(年龄 43±12 岁,56%为男性)。OT-PVC 起源于主动脉瓣和右心室流出道(分别占 44%和 37%)。RF 总时间为 216±87 秒。主要并发症发生率为 0.9%。左心室射血分数(LVEF)由基线时的 47±8%增加至 6 个月时的 53±6%(p<0.001)。神经激素激活明显降低(从 104±69 降至 83±42,p<0.001)。NYHA 心功能分级改善,NYHA-I 级患者比例从 54%增加至 89%(p<0.001),6MWD 从 293±73 增加至 335±59m(p<0.001)。MLHFQ 评分从 32±9 改善至 23±5(p<0.001)。多变量分析显示,LV 收缩末期内径(LVESD)和 6MWD 是 MLHFQ 改善的独立预测因子(对于 LVESD Uβ:-0.26,95%CI [0.44-0.09],p<0.004;对于 6MWD:0.04,95%CI [0.03-0.06],p<0.001)。
OT-PVC 的 RFCA 治疗与左心功能、神经激素激活、功能状态和心衰相关生活质量的改善有关。